Markets:

Overview

News

Currencies

International

Treasuries

Masimo Corporation - Common Stock (NQ:MASI)

131.82 -2.28 (-1.70%)

Streaming Delayed Price Updated: 11:05 AM EST, Feb 11, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Masimo Corporation - Common Stock

< Previous 1 2

...

16 17 18 19 20 21 22 23 Next >

New Study Finds That Use of Masimo SedLine® PSi and DSA May Significantly Reduce Postoperative Delirium

November 15, 2021

From Masimo

Via Business Wire

Masimo to Present in Stifel 2021 Virtual Healthcare Conference

November 11, 2021

From Masimo

Via Business Wire

Masimo Root® with a Multimodal Brain Monitoring Algorithm May Improve Postoperative Neurocognition in Elderly Patients

November 08, 2021

From Masimo

Via Business Wire

Earnings Scheduled For October 26, 2021 ↗

October 26, 2021

Companies Reporting Before The Bell • Veoneer (NYSE:VNE) is likely to report quarterly loss at $0.83 per share on revenue of $408.69 million. • Aarons (NYSE:AAN)...

Via Benzinga

Earnings Scheduled For July 27, 2021 ↗

July 27, 2021

Companies Reporting Before The Bell • Navios Maritime Partners (NYSE:NMM) is projected to report quarterly earnings at $2.93 per share on revenue of $146.03 million....

Via Benzinga

5 Stocks Insiders Are Selling ↗

November 03, 2021

When insiders sell shares, it indicates their concern in the company’s prospects or that they view the stock as being overpriced. Either way, this signals an opportunity to...

Via Benzinga

Masimo Launches Dual SET® Pulse Oximetry

November 01, 2021

From Masimo

Via Business Wire

Masimo (MASI) Q3 2021 Earnings Call Transcript ↗

October 27, 2021

MASI earnings call for the period ending September 30, 2021.

Via The Motley Fool

Topics Earnings

Recap: Masimo Q3 Earnings ↗

October 26, 2021

Masimo (NASDAQ:MASI) reported its Q3 earnings results on Tuesday, October 26, 2021 at 04:05 PM. Here's what investors need to know about the announcement. Earnings Masimo beat...

Via Benzinga

Masimo Reports Third Quarter 2021 Financial Results

October 26, 2021

From Masimo

Via Business Wire

New Study Recommends the Use of Masimo PVi® to Guide Fluid Administration During Major Oncosurgery with Lung Ultrasonography

October 18, 2021

From Masimo

Via Business Wire

Masimo to Report Third Quarter 2021 Financial Results After Market Close on Tuesday, October 26

October 12, 2021

From Masimo

Via Business Wire

Masimo and University Hospitals Partner to Combat Nurse Burnout

October 04, 2021

From Masimo

Via Business Wire

New Study Evaluates the Feasibility of Using Masimo EMMA® Capnography on Mechanically Ventilated Neonates

September 26, 2021

From Masimo

Via Business Wire

Masimo CEO Joe Kiani Appointed to President’s Council of Advisors on Science and Technology

September 22, 2021

From Masimo

Via Business Wire

Masimo Launches Single-patient-use rainbow® SuperSensor™

September 13, 2021

From Masimo

Via Business Wire

Masimo to Present in Morgan Stanley 19th Annual Global Healthcare Conference

September 08, 2021

From Masimo Corporation

Via Business Wire

New Study Investigates the Ability of Masimo ORi™ to Provide Early Warning of Hypoxemia During Endotracheal Intubation in ICU Patients

September 06, 2021

From Masimo

Via Business Wire

Masimo Partners with Penington Institute to Raise Awareness of Harm from Prescription Opioid Overdose

August 31, 2021

From Masimo

Via Business Wire

Masimo SafetyNet Alert™ Launches in Western Europe

August 30, 2021

From Masimo

Via Business Wire

Society for the Advancement of Patient Blood Management (SABM) Publication Recommends Continuous Hemoglobin Monitoring

August 26, 2021

From Masimo

Via Business Wire

The Daily Biotech Pulse: Lilly Strikes $1.6B R&D Collaboration, FSD Pulls Plug On COVID-19 Program, Cassava Sinks On Questions About Alzheimer's Drug ↗

August 25, 2021

ere's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 24) Agenus Inc. (NASDAQ: AGEN)...

Via Benzinga

New Study Evaluates the Use of Masimo PVi® to Monitor Volume Status in Spontaneously Breathing Hemodialysis Patients

August 23, 2021

From Masimo

Via Business Wire

New Study Evaluates the Use of Masimo Bridge® As an Alternative to Opioids

August 16, 2021

From Masimo

Via Business Wire

The Daily Biotech Pulse: Cara's Korsuva Greenlighted By FDA, Clinical Trial Disappointments For Novartis, Theravance, Vertex Inks CRISPR Licensing Deal ↗

August 24, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 23) AbbVie Inc. (NYSE: ABBV) (...

Via Benzinga

Masimo (MASI) Q2 2021 Earnings Call Transcript ↗

July 28, 2021

MASI earnings call for the period ending June 30, 2021.

Via The Motley Fool

Topics Earnings

Masimo: Q2 Earnings Insights ↗

July 27, 2021

Shares of Masimo (NASDAQ:MASI) moved lower in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share increased 10.59% year over year to $...

Via Benzinga

Masimo Reports Second Quarter 2021 Financial Results

July 27, 2021

From Masimo

Via Business Wire

Masimo Earnings Preview ↗

July 26, 2021

On Tuesday, July 27, Masimo (NASDAQ:MASI) will report its last quarter's earnings. Here is Benzinga's preview of the company's release. Net Income, Earnings, And Earnings Per...

Via Benzinga

The Daily Biotech Pulse: ObsEva Surges On Out-Licensing Deal, EyeGate Appoints New CEO, 2 Positive Catalysts For Merck, Candel Therapeutics Debuts ↗

July 27, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 26) Absci, CORP (NASDAQ: ABSI...

Via Benzinga

< Previous 1 2

...

16 17 18 19 20 21 22 23 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.